000 | 01919 a2200493 4500 | ||
---|---|---|---|
005 | 20250515063441.0 | ||
264 | 0 | _c20071127 | |
008 | 200711s 0 0 eng d | ||
022 | _a0300-9572 | ||
024 | 7 |
_a10.1016/j.resuscitation.2007.01.026 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aFalk, Jessica A | |
245 | 0 | 0 |
_aInhibition of peroxynitrite precursors, NO and O2, at the onset of reperfusion improves myocardial recovery. _h[electronic resource] |
260 |
_bResuscitation _cSep 2007 |
||
300 |
_a508-15 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 | _aDisease Models, Animal |
650 | 0 | 4 |
_aEnzyme Inhibitors _xtherapeutic use |
650 | 0 | 4 |
_aFree Radical Scavengers _xtherapeutic use |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aMolsidomine _xanalogs & derivatives |
650 | 0 | 4 |
_aMyocardial Contraction _xdrug effects |
650 | 0 | 4 |
_aMyocardial Reperfusion Injury _xdrug therapy |
650 | 0 | 4 |
_aMyocardium _xmetabolism |
650 | 0 | 4 |
_aNG-Nitroarginine Methyl Ester _xtherapeutic use |
650 | 0 | 4 |
_aNitric Oxide _xantagonists & inhibitors |
650 | 0 | 4 |
_aOxygen Consumption _xdrug effects |
650 | 0 | 4 |
_aPeroxynitrous Acid _xantagonists & inhibitors |
650 | 0 | 4 | _aRats |
650 | 0 | 4 | _aRats, Sprague-Dawley |
650 | 0 | 4 |
_aReactive Oxygen Species _xantagonists & inhibitors |
650 | 0 | 4 | _aRecovery of Function |
650 | 0 | 4 |
_aSodium-Potassium-Exchanging ATPase _xantagonists & inhibitors |
650 | 0 | 4 |
_aSuperoxide Dismutase _xtherapeutic use |
650 | 0 | 4 | _aTreatment Outcome |
650 | 0 | 4 |
_aVentricular Function, Left _xdrug effects |
700 | 1 | _aAune, Sverre E | |
700 | 1 | _aKutala, Vijay K | |
700 | 1 | _aKuppusamy, Periannan | |
700 | 1 | _aAngelos, Mark G | |
773 | 0 |
_tResuscitation _gvol. 74 _gno. 3 _gp. 508-15 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.resuscitation.2007.01.026 _zAvailable from publisher's website |
999 |
_c16970058 _d16970058 |